Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estrogen vs Apricot Kernel Oil in GSM
NCT02869165Phase 4Completed
- Sponsor
- University of Louisville
- Start
- Jan 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Estrogen vaginal cream in genitourinary syndrome of menopause (GSM), sponsored by University of Louisville. Primary endpoint: Vaginal and urinary predominance of anaerobic/fastidious taxonomy of micro-organisms at 3 months. Started Jan 2017; status: completed.
02
Drugs
Estrogen vaginal cream
03
Conditions
genitourinary syndrome of menopause (GSM)
Beyond the preview
Go deeper on NCT02869165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02869165.